These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The METEX study: methotrexate versus expectant management in women with ectopic pregnancy: a randomised controlled trial. van Mello NM; Mol F; Adriaanse AH; Boss EA; Dijkman AB; Doornbos JP; Emanuel MH; Friederich J; Leeuw-Harmsen Lv; Lips JP; van Santbrink EJ; Verhoeve HR; Visser H; Ankum WM; Veen Fv; Mol BW; Hajenius PJ BMC Womens Health; 2008 Jun; 8():10. PubMed ID: 18565217 [TBL] [Abstract][Full Text] [Related]
24. Conservative treatment of ectopic pregnancy by means of a single injection of methotrexate into the gestational sac. Venezia R; Zangara C Acta Eur Fertil; 1989; 20(4):227-30. PubMed ID: 2485123 [TBL] [Abstract][Full Text] [Related]
26. Methotrexate or expectant management in women with an ectopic pregnancy or pregnancy of unknown location and low serum hCG concentrations? A randomized comparison. van Mello NM; Mol F; Verhoeve HR; van Wely M; Adriaanse AH; Boss EA; Dijkman AB; Bayram N; Emanuel MH; Friederich J; van der Leeuw-Harmsen L; Lips JP; Van Kessel MA; Ankum WM; van der Veen F; Mol BW; Hajenius PJ Hum Reprod; 2013 Jan; 28(1):60-7. PubMed ID: 23081873 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of single-dose systemic methotrexate in the treatment of ectopic pregnancy. Glock JL; Johnson JV; Brumsted JR Fertil Steril; 1994 Oct; 62(4):716-21. PubMed ID: 7926078 [TBL] [Abstract][Full Text] [Related]
28. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis. Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445 [TBL] [Abstract][Full Text] [Related]
29. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies. Goh A; Karine P; Kirby A; Williams C; Kapurubandara S Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399 [TBL] [Abstract][Full Text] [Related]
30. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study. Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362 [TBL] [Abstract][Full Text] [Related]
31. Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: a randomized trial. Krag Moeller LB; Moeller C; Thomsen SG; Andersen LF; Lundvall L; Lidegaard Ø; Kjer JJ; Ingemanssen JL; Zobbe V; Floridon C; Petersen J; Ottesen B Acta Obstet Gynecol Scand; 2009; 88(12):1331-7. PubMed ID: 19961341 [TBL] [Abstract][Full Text] [Related]
32. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy. Sowter MC; Farquhar CM; Petrie KJ; Gudex G BJOG; 2001 Feb; 108(2):192-203. PubMed ID: 11236120 [TBL] [Abstract][Full Text] [Related]
33. Ectopic pregnancy; risk factors and comparison of intervention success rates in tubal ectopic pregnancy. Kazandi M; Turan V Clin Exp Obstet Gynecol; 2011; 38(1):67-70. PubMed ID: 21485731 [TBL] [Abstract][Full Text] [Related]
34. Pre- and post-treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy. Natale A; Candiani M; Barbieri M; Calia C; Odorizzi MP; Busacca M Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):87-92. PubMed ID: 15474251 [TBL] [Abstract][Full Text] [Related]
35. Outcome, complications and future fertility in women treated with uterine artery embolization and methotrexate for non-tubal ectopic pregnancy. Krissi H; Hiersch L; Stolovitch N; Nitke S; Wiznitzer A; Peled Y Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():172-6. PubMed ID: 25300059 [TBL] [Abstract][Full Text] [Related]
36. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy. Yıldız A; Bilge O Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015 [TBL] [Abstract][Full Text] [Related]
37. Management of tubal pregnancy with methotrexate. Zakut H; Sadan O; Katz A; Dreval D; Bernstein D Br J Obstet Gynaecol; 1989 Jun; 96(6):725-8. PubMed ID: 2478186 [TBL] [Abstract][Full Text] [Related]
38. Treatment of tubal pregnancy by local injection of methotrexate after adrenaline injection into the mesosalpinx: a report of 25 patients. Kooi S; Kock HC Fertil Steril; 1990 Oct; 54(4):580-4. PubMed ID: 2209877 [TBL] [Abstract][Full Text] [Related]
39. Serum human chorionic gonadotropin clearance curves in patients with interstitial pregnancy treated with systemic methotrexate. Hajenius PJ; Voigt RR; Engelsbel S; Mol BW; Hemrika DJ; Van der Veen F Fertil Steril; 1996 Nov; 66(5):723-8. PubMed ID: 8893674 [TBL] [Abstract][Full Text] [Related]
40. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy. Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]